227 related articles for article (PubMed ID: 19733658)
21. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
Wang S; Jiang T; Ma M; Hu Y; Zhang J
Int J Pharm; 2010 Feb; 386(1-2):249-55. PubMed ID: 19900520
[TBL] [Abstract][Full Text] [Related]
22. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
[TBL] [Abstract][Full Text] [Related]
24. [Research on thymopentin-loaded N-trimethyl chitosan nanoparticles administered through mouth].
Tang SW; Yuan XJ; Zhang ZR; Song QG; He Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):885-8. PubMed ID: 17953385
[TBL] [Abstract][Full Text] [Related]
25. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.
Bal SM; Slütter B; Jiskoot W; Bouwstra JA
Vaccine; 2011 May; 29(23):4025-32. PubMed ID: 21443959
[TBL] [Abstract][Full Text] [Related]
26. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.
Boonyo W; Junginger HE; Waranuch N; Polnok A; Pitaksuteepong T
J Control Release; 2007 Aug; 121(3):168-75. PubMed ID: 17644205
[TBL] [Abstract][Full Text] [Related]
27. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Chen F; Zhang ZR; Huang Y
Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
[TBL] [Abstract][Full Text] [Related]
28. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
[TBL] [Abstract][Full Text] [Related]
29. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
30. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
[TBL] [Abstract][Full Text] [Related]
31. Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine.
Hagenaars N; Mania M; de Jong P; Que I; Nieuwland R; Slütter B; Glansbeek H; Heldens J; van den Bosch H; Löwik C; Kaijzel E; Mastrobattista E; Jiskoot W
J Control Release; 2010 May; 144(1):17-24. PubMed ID: 20100528
[TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE
Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322
[TBL] [Abstract][Full Text] [Related]
33. Preparation of N-trimethyl chitosan-protein nanoparticles intended for vaccine delivery.
Li XY; Li X; Kong XY; Shi S; Guo G; Zhang J; Luo F; Zhao X; Wei YQ; Qian ZY; Yang L
J Nanosci Nanotechnol; 2010 Aug; 10(8):4850-8. PubMed ID: 21125819
[TBL] [Abstract][Full Text] [Related]
34. Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies.
Cevher E; Salomon SK; Makrakis A; Li XW; Brocchini S; Alpar HO
J Microencapsul; 2015; 32(8):755-68. PubMed ID: 26480961
[TBL] [Abstract][Full Text] [Related]
35. Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration.
Liu Q; Zheng X; Zhang C; Shao X; Zhang X; Zhang Q; Jiang X
J Med Virol; 2015 Nov; 87(11):1807-15. PubMed ID: 25959372
[TBL] [Abstract][Full Text] [Related]
36. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
Pirouzmand H; Khameneh B; Tafaghodi M
Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-DNA microparticles as mucosal delivery system: synthesis, characterization and release in vitro.
Li YH; Fan MW; Bian Z; Chen Z; Zhang Q; Yang HR
Chin Med J (Engl); 2005 Jun; 118(11):936-41. PubMed ID: 15978195
[TBL] [Abstract][Full Text] [Related]
38. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
Pawar D; Jaganathan KS
Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
[TBL] [Abstract][Full Text] [Related]
39. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
Borges O; Cordeiro-da-Silva A; Romeijn SG; Amidi M; de Sousa A; Borchard G; Junginger HE
J Control Release; 2006 Sep; 114(3):348-58. PubMed ID: 16905219
[TBL] [Abstract][Full Text] [Related]
40. Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.
Amin M; Jaafari MR; Tafaghodi M
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):225-9. PubMed ID: 19699067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
